SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-429627
Filing Date
2014-12-01
Accepted
2014-12-01 17:27:33
Documents
3
Period of Report
2014-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d829344d8k.htm 8-K 17142
2 EX-99.1 d829344dex991.htm EX-99.1 7235
3 GRAPHIC g829344ex99_1logo.jpg GRAPHIC 13770
  Complete submission text file 0001193125-14-429627.txt   44934
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 141258626
SIC: 2835 In Vitro & In Vivo Diagnostic Substances